{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:59:50Z","timestamp":1792807190230,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Autonoma de Mexico","doi-asserted-by":"publisher","award":["IN202217"],"award-info":[{"award-number":["IN202217"]}],"id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.seizure.2021.07.028","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T11:44:23Z","timestamp":1627299863000},"page":"447-455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Temporal lobe epilepsy: Evaluation of central and systemic immune-inflammatory features associated with drug resistance."],"prefix":"10.1016","volume":"91","author":[{"given":"Andrea","family":"Toledo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Orozco-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Rosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara I.","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris E.","family":"Mart\u00ednez-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladis","family":"Fragoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edda","family":"Sciutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2021.07.028_bib0001","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"45","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.028_bib0002","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.028_bib0003","unstructured":"WHO, 2019. Epilepsy: A public health imperative, Geneva: World Health Organization, Licence: CC BY-NC-SA 3.0 IGO, ISBN 978-92-4-151593-1."},{"key":"10.1016\/j.seizure.2021.07.028_bib0004","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.028_bib0005","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/epi.14596","article-title":"The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis","volume":"59","author":"Kalilani","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.028_bib0006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13760-019-01120-8","article-title":"The current and emerging therapeutic approaches in drug-resistant epilepsy management","volume":"119","author":"Mehdizadeh","year":"2019","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.seizure.2021.07.028_bib0007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.seizure.2016.07.002","article-title":"Antibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questions","volume":"41","author":"Bakpa","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.07.028_bib0008","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1056\/NEJMoa1703784","article-title":"Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery","volume":"377","author":"Blumcke","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2021.07.028_bib0009","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.seizure.2021.07.028_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eplepsyres.2009.09.004","article-title":"Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability","volume":"89","author":"Riazi","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2021.07.028_bib0011","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mcn.2012.06.004","article-title":"Influence of Peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models","volume":"53","author":"Murta","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.seizure.2021.07.028_bib0012","article-title":"Inflammation and reactive oxygen species as disease modifiers in epilepsy","volume":"14","author":"Terrone","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.seizure.2021.07.028_bib0013","article-title":"Peripheral blood lymphocyte phenotypes in Alzheimer and Parkinson's diseases","author":"Garfias","year":"2019","journal-title":"Neurologia"},{"key":"10.1016\/j.seizure.2021.07.028_bib0014","doi-asserted-by":"crossref","DOI":"10.2174\/1381612826666200320121813","article-title":"Magnolia officinalis reduces inflammation and damage induced by recurrent Status epilepticus in immature rats","volume":"26","author":"Vega-Garc\u00eda","year":"2020","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.seizure.2021.07.028_bib0015","doi-asserted-by":"crossref","first-page":"33747","DOI":"10.1074\/jbc.M111.246561","article-title":"Beta-amyloid peptide variants in brains and cerebrospinal fluid from amyloid precursor protein (APP) transgenic mice: comparison with human Alzheimer amyloid","volume":"286","author":"Schieb","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.seizure.2021.07.028_bib0016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"10.1016\/j.seizure.2021.07.028_bib0017","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/epi.12220","article-title":"International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods","volume":"54","author":"Bl\u00fcmcke","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.028_bib0018","doi-asserted-by":"crossref","first-page":"268","DOI":"10.33588\/rn.6506.2017188","article-title":"Barreras de acceso a la cirugia de la epilepsia: revision de la bibliografia [Barriers impeding access to epilepsy surgery: a review of the literature]","volume":"65","author":"Ladino","year":"2017","journal-title":"Rev Neurol"},{"key":"10.1016\/j.seizure.2021.07.028_bib0019","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2011.03036.x","article-title":"Immuno and antiinflammatory therapies in epileptic disorders","volume":"52","author":"\u00d6zkara","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.028_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12974-019-1592-3","article-title":"Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management","volume":"16","author":"Rawat","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.seizure.2021.07.028_bib0021","first-page":"133","article-title":"Pharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studies","volume":"16","author":"Ravizza","year":"2017","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2021.07.028_bib0022","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/08830738050200022201","article-title":"Valproate-induced eosinophilia in children with epilepsy: role of interleukin-5","volume":"20","author":"Makis","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2021.07.028_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-12-2","article-title":"Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder","volume":"12","author":"Elomaa","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.seizure.2021.07.028_bib0024","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1101\/gad.1839510","article-title":"Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure","volume":"24","author":"Phoenix","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.seizure.2021.07.028_bib0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbi.2015.11.016","article-title":"Peripheral leukocyte profile in people with temporal lobe epilepsy reflects the associated proinflammatory state","volume":"53","author":"Vieira","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.seizure.2021.07.028_bib0026","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.seizure.2016.03.006","article-title":"The effects of ketogenic diet on the Th17\/Treg cells imbalance in patients with intractable childhood epilepsy","volume":"38","author":"Ni","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.07.028_bib0027","first-page":"1","article-title":"Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug-resistant epilepsy","volume":"00","author":"Ou\u00e9draogo","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.028_bib0028","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamaneurol.2015.0941","article-title":"Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein","volume":"72","author":"Gershen","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2021.07.028_bib0029","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2007.08.012","article-title":"Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy","volume":"29","author":"Ravizza","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.seizure.2021.07.028_bib0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1267\/ahc.10022","article-title":"Infiltration of T lymphocytes and expression of ICAM-1 in the hippocampus of patients with hippocampal sclerosis","volume":"43","author":"Nakahara","year":"2010","journal-title":"Acta Histochem Cytochem"},{"key":"10.1016\/j.seizure.2021.07.028_bib0031","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1523\/JNEUROSCI.6210-10.2011","article-title":"Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy","volume":"31","author":"Zattoni","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2021.07.028_bib0032","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.anndiagpath.2017.05.009","article-title":"Chronic inflammation in refractory hippocampal sclerosis-related temporal lobe epilepsy","volume":"30","author":"Gales","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.seizure.2021.07.028_bib0033","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00207454.2017.1389928","article-title":"Immunopathology in drug resistant mesial temporal lobe epilepsy with different types of hippocampal sclerosis","volume":"128","author":"Tezer","year":"2018","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.seizure.2021.07.028_bib0034","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2010.06.051","article-title":"Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity","volume":"1353","author":"Marchi","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.seizure.2021.07.028_bib0035","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/ijms18051000","article-title":"Interleukin 17A Promotes Lymphocytes Adhesion and Induces CCL2 and CXCL1 Release from Brain Endothelial Cells","volume":"18","author":"Wojkowska","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.seizure.2021.07.028_bib0036","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a major cytokine in the central nervous system","volume":"8","author":"Erta","year":"2012","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.seizure.2021.07.028_bib0037","first-page":"195","article-title":"Interleukin-1\u03b2 in Central Nervous System Injury and Repair","volume":"1","author":"Hewett","year":"2012","journal-title":"Eur J Neurodegener Dis"},{"key":"10.1016\/j.seizure.2021.07.028_bib0038","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ana.20480","article-title":"Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors","volume":"57","author":"Balosso","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2021.07.028_bib0039","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/epi.14083","article-title":"Longitudinal positron emission tomography imaging of glial cell activation in a mouse model of mesial temporal lobe epilepsy: Toward identification of optimal treatment windows","volume":"59","author":"Nguyen","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.028_bib0040","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/epi.15967","article-title":"Neuroinflammation in neocortical epilepsy measured by PET imaging of translocator protein","volume":"60","author":"Dickstein","year":"2019","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121002594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121002594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:04:03Z","timestamp":1761012243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131121002594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":40,"alternative-id":["S1059131121002594"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2021.07.028","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal lobe epilepsy: Evaluation of central and systemic immune-inflammatory features associated with drug resistance.","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2021.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}